EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Treatment of Apathy in Parkinson’s Disease and Implications for Underlying Pathophysiology

Senan Maher, Eoghan Donlon iD, Gerard Mullane, Richard Walsh, Tim Lynch, Conor Fearon

Journal of Clinical Medicine · 11.04.2024 · 13 (8) · 2216

DOI: 10.3390/jcm13082216 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 11.04.2024. Verfasst von Senan Maher und 5 weiteren Autor:innen. Beteiligte Einrichtung: Dublin Neurological Institute, Mater Misericordiae Hospital, D07 W7XF Dublin, Ireland. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Apathy is a prevalent and highly debilitating non-motor symptom of Parkinson’s disease (PD) that is often overlooked in clinical practice due to its subtle nature. This review aims to provide a comprehensive overview of the current evidence for the treatment of apathy in PD, highlighting recent advancements and emerging therapeutic avenues. In this review, we analyse a diverse array of treatment strategies for apathy in PD, including pharmacological interventions, non-pharmacological approaches, and emerging neuromodulation techniques. We evaluate the efficacy, safety, and limitations of established pharmacotherapies, such as dopaminergic agents, antidepressants, and cognitive enhancers. Additionally, we examine the promising role of non-pharmacological interventions, encompassing psychotherapies and behavioural interventions, in ameliorating apathetic symptoms. Furthermore, this review explores the effects of neuromodulation techniques on apathy, including the modulation of apathy via deep brain stimulation and emerging data on the potential influence of transcranial magnetic stimulation (TMS) on apathy in PD. Ultimately, a deeper understanding of effective treatment strategies for apathy has the potential to significantly improve the quality of life and overall well-being of individuals living with PD.

Schlagwörter

Stichwörter der Autor:innen

ParkinsonsParkinson’s diseaseapathy

Autor:innen und Institutionen

  • Dublin Neurological Institute, Mater Misericordiae Hospital, D07 W7XF Dublin, Ireland.
  • Academic Unit of Neurology, School of Medicine, Trinity College Dublin, D02 R590 Dublin, Ireland.
  • School of Medicine, University College Dublin, D04 V1W8 Dublin, Ireland.

ORCID-Profile: Eoghan Donlon

Zitieren

APA

Maher, S., Donlon, E., Mullane, G., Walsh, R., Lynch, T., & Fearon, C. (2024). Treatment of Apathy in Parkinson’s Disease and Implications for Underlying Pathophysiology. Journal of Clinical Medicine, 13(8), 2216. https://doi.org/10.3390/jcm13082216

Vancouver

Maher S, Donlon E, Mullane G, Walsh R, Lynch T, Fearon C. Treatment of Apathy in Parkinson’s Disease and Implications for Underlying Pathophysiology. Journal of Clinical Medicine. 2024;13(8):2216. doi:10.3390/jcm13082216

BibTeX
@article{Maher2024,
  author = {Maher, Senan and Donlon, Eoghan and Mullane, Gerard and Walsh, Richard and Lynch, Tim and Fearon, Conor},
  title = {Treatment of Apathy in Parkinson’s Disease and Implications for Underlying Pathophysiology},
  journal = {Journal of Clinical Medicine},
  year = {2024},
  volume = {13},
  number = {8},
  pages = {2216},
  doi = {10.3390/jcm13082216}
}
Kostenlos starten →